mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.08 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.09 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.09 |